Chinese Scientists Publish New Gene-Editing Technology

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING: China’s Box Office Snaps Five-Week Decline on Big Domestic Openings; In Depth: The Role of China’s Newly Created National Data Bureau

LATEST: China’s Box Office Snaps Five-Week Decline on Big Domestic Openings; In Depth: The Role of China’s Newly Created National Data Bureau; China’s Scandal-Plagued Semiconductor ‘Big Fund’ Gets New Chief; TikTok Steps Up European User Data Protections Amid Threats of Bans; Business Leaders Push Tech Agenda at China’s ‘Two Sessions’; China to Build 600,000 5G Base Stations in 2023; Xiaomi Goes Toe-to-Toe With Huawei in License, Patent Disputes; China Issues New Rules to Stamp Out Deceptive App Features; Chinese Regulators Question Auto Supplier Over Next-Generation Battery Claims; IQiyi Waters Down Plan to Cash In on Popular Feature After User Uproar; Guangzhou Commits $29 Billion to Local Tech Funds; Game Developer NetEase Teases Chatbot-Generated Dialogue for Mobile Release; China’s No. 2 Chipmaker Posts Record Quarterly Revenue, but Sees Slowing Growth; SMIC Warns of Difficult 2023 After Fourth Quarter Slowdown; Shanghai Bourse Probes AI Firms’ Stock Surge on Chatbot Fervor; NFTs, Metaverse Get Digital Cold Shoulder in Beijing; Baidu Talks Up ERNIE as China’s Answer to ChatGPT; Yangtze Memory Kicks Terminated Workers Out of Apartments; TuSimple Denies Media Report of U.S. Spying Probe; Robotics Firm UBTech Files for Hong Kong IPO

By Matthew Walsh / Jul 17, 2019 01:26 PM / Environment

Photo: IC Photo

Researchers at China’s Peking University published a paper Monday outlining a new gene-editing technology that may have profound effects on the treatment of certain diseases.

Known as LEAPER, the method — described in the British journal Nature Biotechnology — concerns the use of certain cellular molecules that play major roles in gene coding and expression, and avoids several of the pitfalls of the best-known existing gene-editing technology, CRISPR-Cas9.

Check caixinglobal.com later today for the full story.

Contact reporter Matthew Walsh (matthewwalsh@caixin.com)

Share this article

Open WeChat and scan the QR code